|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Postlicensure Safety Sur- veillance for Varicella Vaccine 显示文摘 | Wise RP Salive ME Braun MM | 2000 | JAMA2000，284，10： | 1 |
| 2 | The epidemiology otfatalities reported to the vaccine adverse event reporting system 1990-1997 显示文摘 | Silvers LE Ellenberg SS Wise RP | 2001 | Pharmacoepidemiol Drug Saf2001，10，4： | 1 |
| 3 | The epidemiology of fatalities reported to the vaccine adverse event reporting system 1990-1997显示文摘 | Silvers LE Ellenberg SS Wise RP | 2001 | Pharmaco epidemiology and Drug Safety2001，10，4： | 1 |
| 4 | Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent显示文摘 | Keane J Gershon S Wise RP | 2001 | N Engl J Med2001，345，15： | 1 |
| 5 | A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars显示文摘 | T6r6k TJ Tauxe RV Wise RP Livengood JR Sokolow R Mauvais S Birkness KA Skeels MR Horan JM Foster LR | 1997 | JAMA1997，278，5： | 1 |
| 6 | Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005 显示文摘 | Chaves SS Haber P Walton K Wise RP Izurieta HS Schmid DS Seward JF | 2008 | J Infect Dis2008，197，2： | 1 |
| 7 | A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars显示文摘 | Torok TJ Tauxe RV Wise RP | 1997 | JAMA1997，278，5： | 1 |
| 8 | Hair loss after routineimmunizations 显示文摘 | Wise RP Katonga PK Salive E/\A | 1997 | JAMA1997，278，14： | 1 |
| 9 | Adverse events reported following live,cold-adapted,intranasal influenza vaccine显示文摘 | Izurieta HS Haber P Wise RP et a1 | 2005 | JAMA2005，294，21： | 1 |
| 10 | Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent显示文摘 | Keane J Gershon S Wise RP | 2001 | N Engl J Med2001，345，15： | 1 |
| 11 | Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent显示文摘 | Keane J Gershon S Wise RP | 2001 | NEnglJ Med2001，345，15： | 1 |
| 12 | Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent 显示文摘 | KEANE J GERSHON S WISE RP | 2006 | N Med2006，345，： | 1 |
| 13 | Postlicensure safety surveillance for varicella vaccine 显示文摘 | Wise RP Salive ME Braun MM eta! | 2000 | JAMA2000，284，10： | 1 |
| 14 | Thromboembolic ad- verse events after use of recombinant human coagulation factor VIIa 显示文摘 | O' Connell KA Wood JJ Wise RP | 2006 | JAMA2006，295，3： | 1 |
| 15 | Tuberculosis associatedwith infliximab,a tumor necrosis factor a-neutralizing agent 显示文摘 | KEANE J GERSHON S WISE RP e( al | 2001 | N Engel J Med2001，345，15： | 1 |
| 16 | Tuberculosis associated withinfliximab,a tumor necrosis factor alpha-neutralizing agent显示文摘 | Keane J Gershon S Wise RP | 2001 | N Med2001，345，： | 1 |
| 17 | Tuberculosi associated with infliximab,a tumor necrosis factor alpha-neutralizing agent显示文摘 | Keane J Gershon S Wise RP | 2001 | N Eng J Med2001，345，15： | 1 |
| 18 | Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent显示文摘 | KEANE J GERSHON S WISE RP | 2001 | N Engl J Med2001，345，15： | 1 |
| 19 | Tuberculosis associated with infliximab,a tumor necrosis factor alpha-neutralizing agent显示文摘 | Keane J Gershon S Wise RP | | 0，，15： | 1 |
| 20 | Tuberculosis associated with In- fliximab, a tumor necrosis factor alpha-neutralizing agent 显示文摘 | Keane J Gershon S Wise RP | 2001 | N Engl J Med2001，345，15： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员